Loading company…
Tango Therapeutics develops cancer therapies based on synthetic lethality for patients with specific tumor profiles.
Founded in 2017 and headquartered in Cambridge, US, Tango Therapeutics is led by CEO Barbara Weber, and Tim Lu is its founder. Its therapies are aimed at oncologists and hospitals in North America and Europe, and revenue comes from partnerships and collaborations, including milestone payments and licensing. The company raised USD 80 mn in a PIPE in August 2023, led by Nextech, with other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in